Alirocumab Market, Global Outlook and Forecast 2022-2028
Alirocumab is a human monoclonal antibody. It works by helping the liver reduce levels of 'bad' cholesterol (low-density lipoprotein, or LDL) circulating in your blood.Alirocumab is used in adults with heart disease to lower the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
This report contains market size and forecasts of Alirocumab in global, including the following market information:
Global Alirocumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alirocumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Alirocumab companies in 2021 (%)
The global Alirocumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alirocumab include AK Scientific, Carbosynth, TargetMol Chemicals, Beijing Aomi Jiade Pharmaceutical Technology, Hefei Hirisun Pharmatech, Hubei Widely Chemical Technology, Hubei Xingcheng Biotechnology, Hubei Zhongshan Medical Technology and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alirocumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alirocumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alirocumab Market Segment Percentages, by Type, 2021 (%)
Global Alirocumab Market Segment Percentages, by Application, 2021 (%)
Global Alirocumab Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Alirocumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alirocumab revenues share in global market, 2021 (%)
Key companies Alirocumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Alirocumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Alirocumab in global, including the following market information:
Global Alirocumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alirocumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Alirocumab companies in 2021 (%)
The global Alirocumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alirocumab include AK Scientific, Carbosynth, TargetMol Chemicals, Beijing Aomi Jiade Pharmaceutical Technology, Hefei Hirisun Pharmatech, Hubei Widely Chemical Technology, Hubei Xingcheng Biotechnology, Hubei Zhongshan Medical Technology and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alirocumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alirocumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alirocumab Market Segment Percentages, by Type, 2021 (%)
- Patent
- Generic
Global Alirocumab Market Segment Percentages, by Application, 2021 (%)
- Biochemical Reagents
- Pharmaceutical Intermediates
Global Alirocumab Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Alirocumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alirocumab revenues share in global market, 2021 (%)
Key companies Alirocumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Alirocumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AK Scientific
- Carbosynth
- TargetMol Chemicals
- Beijing Aomi Jiade Pharmaceutical Technology
- Hefei Hirisun Pharmatech
- Hubei Widely Chemical Technology
- Hubei Xingcheng Biotechnology
- Hubei Zhongshan Medical Technology
- Jiangxi Ruiweier Biotechnology
- Kailide Biomedical Technology
- Nantong Feiyu Biological Technology
- Nantong Hi-Future Biotechnology
- Shanghai Baishikai Chemical Technology
- Shanghai Biochempartner
- Shanghai Loulan Biotechnology
- Shanghai Macklin Biochemical
- Shanghai Minkai Biotechnology
- Shanghai Ruihui Chemical Technology
- Shanghai Saimai Biotechnology
- Shanghai Yifei Biotechnology
- Sichuan Weiqi Biotechnology
- Taizhou KEDE Chemical
- Taizhou Kerui Bio-Technology
- Tianmen Hengchang Chemical
- WeiShi Reagent
- Wuhan Dingxintong Pharmaceutical
- Wuhan Fortuna Chemical
- Wuhan Sunrise Technology Development
- Wuhan Weisman Bioengineering
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Alirocumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alirocumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ALIROCUMAB OVERALL MARKET SIZE
2.1 Global Alirocumab Market Size: 2021 VS 2028
2.2 Global Alirocumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Alirocumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Alirocumab Players in Global Market
3.2 Top Global Alirocumab Companies Ranked by Revenue
3.3 Global Alirocumab Revenue by Companies
3.4 Global Alirocumab Sales by Companies
3.5 Global Alirocumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Alirocumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Alirocumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alirocumab Players in Global Market
3.8.1 List of Global Tier 1 Alirocumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Alirocumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Alirocumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Alirocumab Revenue & Forecasts
4.2.1 By Type - Global Alirocumab Revenue, 2017-2022
4.2.2 By Type - Global Alirocumab Revenue, 2023-2028
4.2.3 By Type - Global Alirocumab Revenue Market Share, 2017-2028
4.3 By Type - Global Alirocumab Sales & Forecasts
4.3.1 By Type - Global Alirocumab Sales, 2017-2022
4.3.2 By Type - Global Alirocumab Sales, 2023-2028
4.3.3 By Type - Global Alirocumab Sales Market Share, 2017-2028
4.4 By Type - Global Alirocumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Alirocumab Market Size, 2021 & 2028
5.1.2 Biochemical Reagents
5.1.3 Pharmaceutical Intermediates
5.2 By Application - Global Alirocumab Revenue & Forecasts
5.2.1 By Application - Global Alirocumab Revenue, 2017-2022
5.2.2 By Application - Global Alirocumab Revenue, 2023-2028
5.2.3 By Application - Global Alirocumab Revenue Market Share, 2017-2028
5.3 By Application - Global Alirocumab Sales & Forecasts
5.3.1 By Application - Global Alirocumab Sales, 2017-2022
5.3.2 By Application - Global Alirocumab Sales, 2023-2028
5.3.3 By Application - Global Alirocumab Sales Market Share, 2017-2028
5.4 By Application - Global Alirocumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Alirocumab Market Size, 2021 & 2028
6.2 By Region - Global Alirocumab Revenue & Forecasts
6.2.1 By Region - Global Alirocumab Revenue, 2017-2022
6.2.2 By Region - Global Alirocumab Revenue, 2023-2028
6.2.3 By Region - Global Alirocumab Revenue Market Share, 2017-2028
6.3 By Region - Global Alirocumab Sales & Forecasts
6.3.1 By Region - Global Alirocumab Sales, 2017-2022
6.3.2 By Region - Global Alirocumab Sales, 2023-2028
6.3.3 By Region - Global Alirocumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Alirocumab Revenue, 2017-2028
6.4.2 By Country - North America Alirocumab Sales, 2017-2028
6.4.3 US Alirocumab Market Size, 2017-2028
6.4.4 Canada Alirocumab Market Size, 2017-2028
6.4.5 Mexico Alirocumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Alirocumab Revenue, 2017-2028
6.5.2 By Country - Europe Alirocumab Sales, 2017-2028
6.5.3 Germany Alirocumab Market Size, 2017-2028
6.5.4 France Alirocumab Market Size, 2017-2028
6.5.5 U.K. Alirocumab Market Size, 2017-2028
6.5.6 Italy Alirocumab Market Size, 2017-2028
6.5.7 Russia Alirocumab Market Size, 2017-2028
6.5.8 Nordic Countries Alirocumab Market Size, 2017-2028
6.5.9 Benelux Alirocumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Alirocumab Revenue, 2017-2028
6.6.2 By Region - Asia Alirocumab Sales, 2017-2028
6.6.3 China Alirocumab Market Size, 2017-2028
6.6.4 Japan Alirocumab Market Size, 2017-2028
6.6.5 South Korea Alirocumab Market Size, 2017-2028
6.6.6 Southeast Asia Alirocumab Market Size, 2017-2028
6.6.7 India Alirocumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Alirocumab Revenue, 2017-2028
6.7.2 By Country - South America Alirocumab Sales, 2017-2028
6.7.3 Brazil Alirocumab Market Size, 2017-2028
6.7.4 Argentina Alirocumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Alirocumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Alirocumab Sales, 2017-2028
6.8.3 Turkey Alirocumab Market Size, 2017-2028
6.8.4 Israel Alirocumab Market Size, 2017-2028
6.8.5 Saudi Arabia Alirocumab Market Size, 2017-2028
6.8.6 UAE Alirocumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AK Scientific
7.1.1 AK Scientific Corporate Summary
7.1.2 AK Scientific Business Overview
7.1.3 AK Scientific Alirocumab Major Product Offerings
7.1.4 AK Scientific Alirocumab Sales and Revenue in Global (2017-2022)
7.1.5 AK Scientific Key News
7.2 Carbosynth
7.2.1 Carbosynth Corporate Summary
7.2.2 Carbosynth Business Overview
7.2.3 Carbosynth Alirocumab Major Product Offerings
7.2.4 Carbosynth Alirocumab Sales and Revenue in Global (2017-2022)
7.2.5 Carbosynth Key News
7.3 TargetMol Chemicals
7.3.1 TargetMol Chemicals Corporate Summary
7.3.2 TargetMol Chemicals Business Overview
7.3.3 TargetMol Chemicals Alirocumab Major Product Offerings
7.3.4 TargetMol Chemicals Alirocumab Sales and Revenue in Global (2017-2022)
7.3.5 TargetMol Chemicals Key News
7.4 Beijing Aomi Jiade Pharmaceutical Technology
7.4.1 Beijing Aomi Jiade Pharmaceutical Technology Corporate Summary
7.4.2 Beijing Aomi Jiade Pharmaceutical Technology Business Overview
7.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Major Product Offerings
7.4.4 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.4.5 Beijing Aomi Jiade Pharmaceutical Technology Key News
7.5 Hefei Hirisun Pharmatech
7.5.1 Hefei Hirisun Pharmatech Corporate Summary
7.5.2 Hefei Hirisun Pharmatech Business Overview
7.5.3 Hefei Hirisun Pharmatech Alirocumab Major Product Offerings
7.5.4 Hefei Hirisun Pharmatech Alirocumab Sales and Revenue in Global (2017-2022)
7.5.5 Hefei Hirisun Pharmatech Key News
7.6 Hubei Widely Chemical Technology
7.6.1 Hubei Widely Chemical Technology Corporate Summary
7.6.2 Hubei Widely Chemical Technology Business Overview
7.6.3 Hubei Widely Chemical Technology Alirocumab Major Product Offerings
7.6.4 Hubei Widely Chemical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.6.5 Hubei Widely Chemical Technology Key News
7.7 Hubei Xingcheng Biotechnology
7.7.1 Hubei Xingcheng Biotechnology Corporate Summary
7.7.2 Hubei Xingcheng Biotechnology Business Overview
7.7.3 Hubei Xingcheng Biotechnology Alirocumab Major Product Offerings
7.7.4 Hubei Xingcheng Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.7.5 Hubei Xingcheng Biotechnology Key News
7.8 Hubei Zhongshan Medical Technology
7.8.1 Hubei Zhongshan Medical Technology Corporate Summary
7.8.2 Hubei Zhongshan Medical Technology Business Overview
7.8.3 Hubei Zhongshan Medical Technology Alirocumab Major Product Offerings
7.8.4 Hubei Zhongshan Medical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.8.5 Hubei Zhongshan Medical Technology Key News
7.9 Jiangxi Ruiweier Biotechnology
7.9.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.9.2 Jiangxi Ruiweier Biotechnology Business Overview
7.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Major Product Offerings
7.9.4 Jiangxi Ruiweier Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.9.5 Jiangxi Ruiweier Biotechnology Key News
7.10 Kailide Biomedical Technology
7.10.1 Kailide Biomedical Technology Corporate Summary
7.10.2 Kailide Biomedical Technology Business Overview
7.10.3 Kailide Biomedical Technology Alirocumab Major Product Offerings
7.10.4 Kailide Biomedical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.10.5 Kailide Biomedical Technology Key News
7.11 Nantong Feiyu Biological Technology
7.11.1 Nantong Feiyu Biological Technology Corporate Summary
7.11.2 Nantong Feiyu Biological Technology Alirocumab Business Overview
7.11.3 Nantong Feiyu Biological Technology Alirocumab Major Product Offerings
7.11.4 Nantong Feiyu Biological Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.11.5 Nantong Feiyu Biological Technology Key News
7.12 Nantong Hi-Future Biotechnology
7.12.1 Nantong Hi-Future Biotechnology Corporate Summary
7.12.2 Nantong Hi-Future Biotechnology Alirocumab Business Overview
7.12.3 Nantong Hi-Future Biotechnology Alirocumab Major Product Offerings
7.12.4 Nantong Hi-Future Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.12.5 Nantong Hi-Future Biotechnology Key News
7.13 Shanghai Baishikai Chemical Technology
7.13.1 Shanghai Baishikai Chemical Technology Corporate Summary
7.13.2 Shanghai Baishikai Chemical Technology Alirocumab Business Overview
7.13.3 Shanghai Baishikai Chemical Technology Alirocumab Major Product Offerings
7.13.4 Shanghai Baishikai Chemical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai Baishikai Chemical Technology Key News
7.14 Shanghai Biochempartner
7.14.1 Shanghai Biochempartner Corporate Summary
7.14.2 Shanghai Biochempartner Business Overview
7.14.3 Shanghai Biochempartner Alirocumab Major Product Offerings
7.14.4 Shanghai Biochempartner Alirocumab Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Biochempartner Key News
7.15 Shanghai Loulan Biotechnology
7.15.1 Shanghai Loulan Biotechnology Corporate Summary
7.15.2 Shanghai Loulan Biotechnology Business Overview
7.15.3 Shanghai Loulan Biotechnology Alirocumab Major Product Offerings
7.15.4 Shanghai Loulan Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Loulan Biotechnology Key News
7.16 Shanghai Macklin Biochemical
7.16.1 Shanghai Macklin Biochemical Corporate Summary
7.16.2 Shanghai Macklin Biochemical Business Overview
7.16.3 Shanghai Macklin Biochemical Alirocumab Major Product Offerings
7.16.4 Shanghai Macklin Biochemical Alirocumab Sales and Revenue in Global (2017-2022)
7.16.5 Shanghai Macklin Biochemical Key News
7.17 Shanghai Minkai Biotechnology
7.17.1 Shanghai Minkai Biotechnology Corporate Summary
7.17.2 Shanghai Minkai Biotechnology Business Overview
7.17.3 Shanghai Minkai Biotechnology Alirocumab Major Product Offerings
7.17.4 Shanghai Minkai Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.17.5 Shanghai Minkai Biotechnology Key News
7.18 Shanghai Ruihui Chemical Technology
7.18.1 Shanghai Ruihui Chemical Technology Corporate Summary
7.18.2 Shanghai Ruihui Chemical Technology Business Overview
7.18.3 Shanghai Ruihui Chemical Technology Alirocumab Major Product Offerings
7.18.4 Shanghai Ruihui Chemical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.18.5 Shanghai Ruihui Chemical Technology Key News
7.19 Shanghai Saimai Biotechnology
7.19.1 Shanghai Saimai Biotechnology Corporate Summary
7.19.2 Shanghai Saimai Biotechnology Business Overview
7.19.3 Shanghai Saimai Biotechnology Alirocumab Major Product Offerings
7.19.4 Shanghai Saimai Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.19.5 Shanghai Saimai Biotechnology Key News
7.20 Shanghai Yifei Biotechnology
7.20.1 Shanghai Yifei Biotechnology Corporate Summary
7.20.2 Shanghai Yifei Biotechnology Business Overview
7.20.3 Shanghai Yifei Biotechnology Alirocumab Major Product Offerings
7.20.4 Shanghai Yifei Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.20.5 Shanghai Yifei Biotechnology Key News
7.21 Sichuan Weiqi Biotechnology
7.21.1 Sichuan Weiqi Biotechnology Corporate Summary
7.21.2 Sichuan Weiqi Biotechnology Business Overview
7.21.3 Sichuan Weiqi Biotechnology Alirocumab Major Product Offerings
7.21.4 Sichuan Weiqi Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.21.5 Sichuan Weiqi Biotechnology Key News
7.22 Taizhou KEDE Chemical
7.22.1 Taizhou KEDE Chemical Corporate Summary
7.22.2 Taizhou KEDE Chemical Business Overview
7.22.3 Taizhou KEDE Chemical Alirocumab Major Product Offerings
7.22.4 Taizhou KEDE Chemical Alirocumab Sales and Revenue in Global (2017-2022)
7.22.5 Taizhou KEDE Chemical Key News
7.23 Taizhou Kerui Bio-Technology
7.23.1 Taizhou Kerui Bio-Technology Corporate Summary
7.23.2 Taizhou Kerui Bio-Technology Business Overview
7.23.3 Taizhou Kerui Bio-Technology Alirocumab Major Product Offerings
7.23.4 Taizhou Kerui Bio-Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.23.5 Taizhou Kerui Bio-Technology Key News
7.24 Tianmen Hengchang Chemical
7.24.1 Tianmen Hengchang Chemical Corporate Summary
7.24.2 Tianmen Hengchang Chemical Business Overview
7.24.3 Tianmen Hengchang Chemical Alirocumab Major Product Offerings
7.24.4 Tianmen Hengchang Chemical Alirocumab Sales and Revenue in Global (2017-2022)
7.24.5 Tianmen Hengchang Chemical Key News
7.25 WeiShi Reagent
7.25.1 WeiShi Reagent Corporate Summary
7.25.2 WeiShi Reagent Business Overview
7.25.3 WeiShi Reagent Alirocumab Major Product Offerings
7.25.4 WeiShi Reagent Alirocumab Sales and Revenue in Global (2017-2022)
7.25.5 WeiShi Reagent Key News
7.26 Wuhan Dingxintong Pharmaceutical
7.26.1 Wuhan Dingxintong Pharmaceutical Corporate Summary
7.26.2 Wuhan Dingxintong Pharmaceutical Business Overview
7.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Major Product Offerings
7.26.4 Wuhan Dingxintong Pharmaceutical Alirocumab Sales and Revenue in Global (2017-2022)
7.26.5 Wuhan Dingxintong Pharmaceutical Key News
7.27 Wuhan Fortuna Chemical
7.27.1 Wuhan Fortuna Chemical Corporate Summary
7.27.2 Wuhan Fortuna Chemical Business Overview
7.27.3 Wuhan Fortuna Chemical Alirocumab Major Product Offerings
7.27.4 Wuhan Fortuna Chemical Alirocumab Sales and Revenue in Global (2017-2022)
7.27.5 Wuhan Fortuna Chemical Key News
7.28 Wuhan Sunrise Technology Development
7.28.1 Wuhan Sunrise Technology Development Corporate Summary
7.28.2 Wuhan Sunrise Technology Development Business Overview
7.28.3 Wuhan Sunrise Technology Development Alirocumab Major Product Offerings
7.28.4 Wuhan Sunrise Technology Development Alirocumab Sales and Revenue in Global (2017-2022)
7.28.5 Wuhan Sunrise Technology Development Key News
7.29 Wuhan Weisman Bioengineering
7.29.1 Wuhan Weisman Bioengineering Corporate Summary
7.29.2 Wuhan Weisman Bioengineering Business Overview
7.29.3 Wuhan Weisman Bioengineering Alirocumab Major Product Offerings
7.29.4 Wuhan Weisman Bioengineering Alirocumab Sales and Revenue in Global (2017-2022)
7.29.5 Wuhan Weisman Bioengineering Key News
8 GLOBAL ALIROCUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Alirocumab Production Capacity, 2017-2028
8.2 Alirocumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Alirocumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ALIROCUMAB SUPPLY CHAIN ANALYSIS
10.1 Alirocumab Industry Value Chain
10.2 Alirocumab Upstream Market
10.3 Alirocumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Alirocumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Alirocumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alirocumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ALIROCUMAB OVERALL MARKET SIZE
2.1 Global Alirocumab Market Size: 2021 VS 2028
2.2 Global Alirocumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Alirocumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Alirocumab Players in Global Market
3.2 Top Global Alirocumab Companies Ranked by Revenue
3.3 Global Alirocumab Revenue by Companies
3.4 Global Alirocumab Sales by Companies
3.5 Global Alirocumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Alirocumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Alirocumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alirocumab Players in Global Market
3.8.1 List of Global Tier 1 Alirocumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Alirocumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Alirocumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Alirocumab Revenue & Forecasts
4.2.1 By Type - Global Alirocumab Revenue, 2017-2022
4.2.2 By Type - Global Alirocumab Revenue, 2023-2028
4.2.3 By Type - Global Alirocumab Revenue Market Share, 2017-2028
4.3 By Type - Global Alirocumab Sales & Forecasts
4.3.1 By Type - Global Alirocumab Sales, 2017-2022
4.3.2 By Type - Global Alirocumab Sales, 2023-2028
4.3.3 By Type - Global Alirocumab Sales Market Share, 2017-2028
4.4 By Type - Global Alirocumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Alirocumab Market Size, 2021 & 2028
5.1.2 Biochemical Reagents
5.1.3 Pharmaceutical Intermediates
5.2 By Application - Global Alirocumab Revenue & Forecasts
5.2.1 By Application - Global Alirocumab Revenue, 2017-2022
5.2.2 By Application - Global Alirocumab Revenue, 2023-2028
5.2.3 By Application - Global Alirocumab Revenue Market Share, 2017-2028
5.3 By Application - Global Alirocumab Sales & Forecasts
5.3.1 By Application - Global Alirocumab Sales, 2017-2022
5.3.2 By Application - Global Alirocumab Sales, 2023-2028
5.3.3 By Application - Global Alirocumab Sales Market Share, 2017-2028
5.4 By Application - Global Alirocumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Alirocumab Market Size, 2021 & 2028
6.2 By Region - Global Alirocumab Revenue & Forecasts
6.2.1 By Region - Global Alirocumab Revenue, 2017-2022
6.2.2 By Region - Global Alirocumab Revenue, 2023-2028
6.2.3 By Region - Global Alirocumab Revenue Market Share, 2017-2028
6.3 By Region - Global Alirocumab Sales & Forecasts
6.3.1 By Region - Global Alirocumab Sales, 2017-2022
6.3.2 By Region - Global Alirocumab Sales, 2023-2028
6.3.3 By Region - Global Alirocumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Alirocumab Revenue, 2017-2028
6.4.2 By Country - North America Alirocumab Sales, 2017-2028
6.4.3 US Alirocumab Market Size, 2017-2028
6.4.4 Canada Alirocumab Market Size, 2017-2028
6.4.5 Mexico Alirocumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Alirocumab Revenue, 2017-2028
6.5.2 By Country - Europe Alirocumab Sales, 2017-2028
6.5.3 Germany Alirocumab Market Size, 2017-2028
6.5.4 France Alirocumab Market Size, 2017-2028
6.5.5 U.K. Alirocumab Market Size, 2017-2028
6.5.6 Italy Alirocumab Market Size, 2017-2028
6.5.7 Russia Alirocumab Market Size, 2017-2028
6.5.8 Nordic Countries Alirocumab Market Size, 2017-2028
6.5.9 Benelux Alirocumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Alirocumab Revenue, 2017-2028
6.6.2 By Region - Asia Alirocumab Sales, 2017-2028
6.6.3 China Alirocumab Market Size, 2017-2028
6.6.4 Japan Alirocumab Market Size, 2017-2028
6.6.5 South Korea Alirocumab Market Size, 2017-2028
6.6.6 Southeast Asia Alirocumab Market Size, 2017-2028
6.6.7 India Alirocumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Alirocumab Revenue, 2017-2028
6.7.2 By Country - South America Alirocumab Sales, 2017-2028
6.7.3 Brazil Alirocumab Market Size, 2017-2028
6.7.4 Argentina Alirocumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Alirocumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Alirocumab Sales, 2017-2028
6.8.3 Turkey Alirocumab Market Size, 2017-2028
6.8.4 Israel Alirocumab Market Size, 2017-2028
6.8.5 Saudi Arabia Alirocumab Market Size, 2017-2028
6.8.6 UAE Alirocumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AK Scientific
7.1.1 AK Scientific Corporate Summary
7.1.2 AK Scientific Business Overview
7.1.3 AK Scientific Alirocumab Major Product Offerings
7.1.4 AK Scientific Alirocumab Sales and Revenue in Global (2017-2022)
7.1.5 AK Scientific Key News
7.2 Carbosynth
7.2.1 Carbosynth Corporate Summary
7.2.2 Carbosynth Business Overview
7.2.3 Carbosynth Alirocumab Major Product Offerings
7.2.4 Carbosynth Alirocumab Sales and Revenue in Global (2017-2022)
7.2.5 Carbosynth Key News
7.3 TargetMol Chemicals
7.3.1 TargetMol Chemicals Corporate Summary
7.3.2 TargetMol Chemicals Business Overview
7.3.3 TargetMol Chemicals Alirocumab Major Product Offerings
7.3.4 TargetMol Chemicals Alirocumab Sales and Revenue in Global (2017-2022)
7.3.5 TargetMol Chemicals Key News
7.4 Beijing Aomi Jiade Pharmaceutical Technology
7.4.1 Beijing Aomi Jiade Pharmaceutical Technology Corporate Summary
7.4.2 Beijing Aomi Jiade Pharmaceutical Technology Business Overview
7.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Major Product Offerings
7.4.4 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.4.5 Beijing Aomi Jiade Pharmaceutical Technology Key News
7.5 Hefei Hirisun Pharmatech
7.5.1 Hefei Hirisun Pharmatech Corporate Summary
7.5.2 Hefei Hirisun Pharmatech Business Overview
7.5.3 Hefei Hirisun Pharmatech Alirocumab Major Product Offerings
7.5.4 Hefei Hirisun Pharmatech Alirocumab Sales and Revenue in Global (2017-2022)
7.5.5 Hefei Hirisun Pharmatech Key News
7.6 Hubei Widely Chemical Technology
7.6.1 Hubei Widely Chemical Technology Corporate Summary
7.6.2 Hubei Widely Chemical Technology Business Overview
7.6.3 Hubei Widely Chemical Technology Alirocumab Major Product Offerings
7.6.4 Hubei Widely Chemical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.6.5 Hubei Widely Chemical Technology Key News
7.7 Hubei Xingcheng Biotechnology
7.7.1 Hubei Xingcheng Biotechnology Corporate Summary
7.7.2 Hubei Xingcheng Biotechnology Business Overview
7.7.3 Hubei Xingcheng Biotechnology Alirocumab Major Product Offerings
7.7.4 Hubei Xingcheng Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.7.5 Hubei Xingcheng Biotechnology Key News
7.8 Hubei Zhongshan Medical Technology
7.8.1 Hubei Zhongshan Medical Technology Corporate Summary
7.8.2 Hubei Zhongshan Medical Technology Business Overview
7.8.3 Hubei Zhongshan Medical Technology Alirocumab Major Product Offerings
7.8.4 Hubei Zhongshan Medical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.8.5 Hubei Zhongshan Medical Technology Key News
7.9 Jiangxi Ruiweier Biotechnology
7.9.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.9.2 Jiangxi Ruiweier Biotechnology Business Overview
7.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Major Product Offerings
7.9.4 Jiangxi Ruiweier Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.9.5 Jiangxi Ruiweier Biotechnology Key News
7.10 Kailide Biomedical Technology
7.10.1 Kailide Biomedical Technology Corporate Summary
7.10.2 Kailide Biomedical Technology Business Overview
7.10.3 Kailide Biomedical Technology Alirocumab Major Product Offerings
7.10.4 Kailide Biomedical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.10.5 Kailide Biomedical Technology Key News
7.11 Nantong Feiyu Biological Technology
7.11.1 Nantong Feiyu Biological Technology Corporate Summary
7.11.2 Nantong Feiyu Biological Technology Alirocumab Business Overview
7.11.3 Nantong Feiyu Biological Technology Alirocumab Major Product Offerings
7.11.4 Nantong Feiyu Biological Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.11.5 Nantong Feiyu Biological Technology Key News
7.12 Nantong Hi-Future Biotechnology
7.12.1 Nantong Hi-Future Biotechnology Corporate Summary
7.12.2 Nantong Hi-Future Biotechnology Alirocumab Business Overview
7.12.3 Nantong Hi-Future Biotechnology Alirocumab Major Product Offerings
7.12.4 Nantong Hi-Future Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.12.5 Nantong Hi-Future Biotechnology Key News
7.13 Shanghai Baishikai Chemical Technology
7.13.1 Shanghai Baishikai Chemical Technology Corporate Summary
7.13.2 Shanghai Baishikai Chemical Technology Alirocumab Business Overview
7.13.3 Shanghai Baishikai Chemical Technology Alirocumab Major Product Offerings
7.13.4 Shanghai Baishikai Chemical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai Baishikai Chemical Technology Key News
7.14 Shanghai Biochempartner
7.14.1 Shanghai Biochempartner Corporate Summary
7.14.2 Shanghai Biochempartner Business Overview
7.14.3 Shanghai Biochempartner Alirocumab Major Product Offerings
7.14.4 Shanghai Biochempartner Alirocumab Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Biochempartner Key News
7.15 Shanghai Loulan Biotechnology
7.15.1 Shanghai Loulan Biotechnology Corporate Summary
7.15.2 Shanghai Loulan Biotechnology Business Overview
7.15.3 Shanghai Loulan Biotechnology Alirocumab Major Product Offerings
7.15.4 Shanghai Loulan Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Loulan Biotechnology Key News
7.16 Shanghai Macklin Biochemical
7.16.1 Shanghai Macklin Biochemical Corporate Summary
7.16.2 Shanghai Macklin Biochemical Business Overview
7.16.3 Shanghai Macklin Biochemical Alirocumab Major Product Offerings
7.16.4 Shanghai Macklin Biochemical Alirocumab Sales and Revenue in Global (2017-2022)
7.16.5 Shanghai Macklin Biochemical Key News
7.17 Shanghai Minkai Biotechnology
7.17.1 Shanghai Minkai Biotechnology Corporate Summary
7.17.2 Shanghai Minkai Biotechnology Business Overview
7.17.3 Shanghai Minkai Biotechnology Alirocumab Major Product Offerings
7.17.4 Shanghai Minkai Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.17.5 Shanghai Minkai Biotechnology Key News
7.18 Shanghai Ruihui Chemical Technology
7.18.1 Shanghai Ruihui Chemical Technology Corporate Summary
7.18.2 Shanghai Ruihui Chemical Technology Business Overview
7.18.3 Shanghai Ruihui Chemical Technology Alirocumab Major Product Offerings
7.18.4 Shanghai Ruihui Chemical Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.18.5 Shanghai Ruihui Chemical Technology Key News
7.19 Shanghai Saimai Biotechnology
7.19.1 Shanghai Saimai Biotechnology Corporate Summary
7.19.2 Shanghai Saimai Biotechnology Business Overview
7.19.3 Shanghai Saimai Biotechnology Alirocumab Major Product Offerings
7.19.4 Shanghai Saimai Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.19.5 Shanghai Saimai Biotechnology Key News
7.20 Shanghai Yifei Biotechnology
7.20.1 Shanghai Yifei Biotechnology Corporate Summary
7.20.2 Shanghai Yifei Biotechnology Business Overview
7.20.3 Shanghai Yifei Biotechnology Alirocumab Major Product Offerings
7.20.4 Shanghai Yifei Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.20.5 Shanghai Yifei Biotechnology Key News
7.21 Sichuan Weiqi Biotechnology
7.21.1 Sichuan Weiqi Biotechnology Corporate Summary
7.21.2 Sichuan Weiqi Biotechnology Business Overview
7.21.3 Sichuan Weiqi Biotechnology Alirocumab Major Product Offerings
7.21.4 Sichuan Weiqi Biotechnology Alirocumab Sales and Revenue in Global (2017-2022)
7.21.5 Sichuan Weiqi Biotechnology Key News
7.22 Taizhou KEDE Chemical
7.22.1 Taizhou KEDE Chemical Corporate Summary
7.22.2 Taizhou KEDE Chemical Business Overview
7.22.3 Taizhou KEDE Chemical Alirocumab Major Product Offerings
7.22.4 Taizhou KEDE Chemical Alirocumab Sales and Revenue in Global (2017-2022)
7.22.5 Taizhou KEDE Chemical Key News
7.23 Taizhou Kerui Bio-Technology
7.23.1 Taizhou Kerui Bio-Technology Corporate Summary
7.23.2 Taizhou Kerui Bio-Technology Business Overview
7.23.3 Taizhou Kerui Bio-Technology Alirocumab Major Product Offerings
7.23.4 Taizhou Kerui Bio-Technology Alirocumab Sales and Revenue in Global (2017-2022)
7.23.5 Taizhou Kerui Bio-Technology Key News
7.24 Tianmen Hengchang Chemical
7.24.1 Tianmen Hengchang Chemical Corporate Summary
7.24.2 Tianmen Hengchang Chemical Business Overview
7.24.3 Tianmen Hengchang Chemical Alirocumab Major Product Offerings
7.24.4 Tianmen Hengchang Chemical Alirocumab Sales and Revenue in Global (2017-2022)
7.24.5 Tianmen Hengchang Chemical Key News
7.25 WeiShi Reagent
7.25.1 WeiShi Reagent Corporate Summary
7.25.2 WeiShi Reagent Business Overview
7.25.3 WeiShi Reagent Alirocumab Major Product Offerings
7.25.4 WeiShi Reagent Alirocumab Sales and Revenue in Global (2017-2022)
7.25.5 WeiShi Reagent Key News
7.26 Wuhan Dingxintong Pharmaceutical
7.26.1 Wuhan Dingxintong Pharmaceutical Corporate Summary
7.26.2 Wuhan Dingxintong Pharmaceutical Business Overview
7.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Major Product Offerings
7.26.4 Wuhan Dingxintong Pharmaceutical Alirocumab Sales and Revenue in Global (2017-2022)
7.26.5 Wuhan Dingxintong Pharmaceutical Key News
7.27 Wuhan Fortuna Chemical
7.27.1 Wuhan Fortuna Chemical Corporate Summary
7.27.2 Wuhan Fortuna Chemical Business Overview
7.27.3 Wuhan Fortuna Chemical Alirocumab Major Product Offerings
7.27.4 Wuhan Fortuna Chemical Alirocumab Sales and Revenue in Global (2017-2022)
7.27.5 Wuhan Fortuna Chemical Key News
7.28 Wuhan Sunrise Technology Development
7.28.1 Wuhan Sunrise Technology Development Corporate Summary
7.28.2 Wuhan Sunrise Technology Development Business Overview
7.28.3 Wuhan Sunrise Technology Development Alirocumab Major Product Offerings
7.28.4 Wuhan Sunrise Technology Development Alirocumab Sales and Revenue in Global (2017-2022)
7.28.5 Wuhan Sunrise Technology Development Key News
7.29 Wuhan Weisman Bioengineering
7.29.1 Wuhan Weisman Bioengineering Corporate Summary
7.29.2 Wuhan Weisman Bioengineering Business Overview
7.29.3 Wuhan Weisman Bioengineering Alirocumab Major Product Offerings
7.29.4 Wuhan Weisman Bioengineering Alirocumab Sales and Revenue in Global (2017-2022)
7.29.5 Wuhan Weisman Bioengineering Key News
8 GLOBAL ALIROCUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Alirocumab Production Capacity, 2017-2028
8.2 Alirocumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Alirocumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ALIROCUMAB SUPPLY CHAIN ANALYSIS
10.1 Alirocumab Industry Value Chain
10.2 Alirocumab Upstream Market
10.3 Alirocumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Alirocumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Alirocumab in Global Market
Table 2. Top Alirocumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Alirocumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Alirocumab Revenue Share by Companies, 2017-2022
Table 5. Global Alirocumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Alirocumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Alirocumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Alirocumab Product Type
Table 9. List of Global Tier 1 Alirocumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alirocumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alirocumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Alirocumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Alirocumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Alirocumab Sales (Kg), 2017-2022
Table 15. By Type - Global Alirocumab Sales (Kg), 2023-2028
Table 16. By Application – Global Alirocumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Alirocumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Alirocumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Alirocumab Sales (Kg), 2017-2022
Table 20. By Application - Global Alirocumab Sales (Kg), 2023-2028
Table 21. By Region – Global Alirocumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Alirocumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Alirocumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Alirocumab Sales (Kg), 2017-2022
Table 25. By Region - Global Alirocumab Sales (Kg), 2023-2028
Table 26. By Country - North America Alirocumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Alirocumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Alirocumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Alirocumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Alirocumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Alirocumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Alirocumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Alirocumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Alirocumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Alirocumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Alirocumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Alirocumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Alirocumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Alirocumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Alirocumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Alirocumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Alirocumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Alirocumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Alirocumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Alirocumab Sales, (Kg), 2023-2028
Table 46. AK Scientific Corporate Summary
Table 47. AK Scientific Alirocumab Product Offerings
Table 48. AK Scientific Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Carbosynth Corporate Summary
Table 50. Carbosynth Alirocumab Product Offerings
Table 51. Carbosynth Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. TargetMol Chemicals Corporate Summary
Table 53. TargetMol Chemicals Alirocumab Product Offerings
Table 54. TargetMol Chemicals Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Beijing Aomi Jiade Pharmaceutical Technology Corporate Summary
Table 56. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offerings
Table 57. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Hefei Hirisun Pharmatech Corporate Summary
Table 59. Hefei Hirisun Pharmatech Alirocumab Product Offerings
Table 60. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Hubei Widely Chemical Technology Corporate Summary
Table 62. Hubei Widely Chemical Technology Alirocumab Product Offerings
Table 63. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Hubei Xingcheng Biotechnology Corporate Summary
Table 65. Hubei Xingcheng Biotechnology Alirocumab Product Offerings
Table 66. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Hubei Zhongshan Medical Technology Corporate Summary
Table 68. Hubei Zhongshan Medical Technology Alirocumab Product Offerings
Table 69. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 71. Jiangxi Ruiweier Biotechnology Alirocumab Product Offerings
Table 72. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Kailide Biomedical Technology Corporate Summary
Table 74. Kailide Biomedical Technology Alirocumab Product Offerings
Table 75. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Nantong Feiyu Biological Technology Corporate Summary
Table 77. Nantong Feiyu Biological Technology Alirocumab Product Offerings
Table 78. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Nantong Hi-Future Biotechnology Corporate Summary
Table 80. Nantong Hi-Future Biotechnology Alirocumab Product Offerings
Table 81. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Shanghai Baishikai Chemical Technology Corporate Summary
Table 83. Shanghai Baishikai Chemical Technology Alirocumab Product Offerings
Table 84. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Shanghai Biochempartner Corporate Summary
Table 86. Shanghai Biochempartner Alirocumab Product Offerings
Table 87. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Shanghai Loulan Biotechnology Corporate Summary
Table 89. Shanghai Loulan Biotechnology Alirocumab Product Offerings
Table 90. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Shanghai Macklin Biochemical Corporate Summary
Table 92. Shanghai Macklin Biochemical Alirocumab Product Offerings
Table 93. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Shanghai Minkai Biotechnology Corporate Summary
Table 95. Shanghai Minkai Biotechnology Alirocumab Product Offerings
Table 96. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 97. Shanghai Ruihui Chemical Technology Corporate Summary
Table 98. Shanghai Ruihui Chemical Technology Alirocumab Product Offerings
Table 99. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 100. Shanghai Saimai Biotechnology Corporate Summary
Table 101. Shanghai Saimai Biotechnology Alirocumab Product Offerings
Table 102. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 103. Shanghai Yifei Biotechnology Corporate Summary
Table 104. Shanghai Yifei Biotechnology Alirocumab Product Offerings
Table 105. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 106. Sichuan Weiqi Biotechnology Corporate Summary
Table 107. Sichuan Weiqi Biotechnology Alirocumab Product Offerings
Table 108. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 109. Taizhou KEDE Chemical Corporate Summary
Table 110. Taizhou KEDE Chemical Alirocumab Product Offerings
Table 111. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 112. Taizhou Kerui Bio-Technology Corporate Summary
Table 113. Taizhou Kerui Bio-Technology Alirocumab Product Offerings
Table 114. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 115. Tianmen Hengchang Chemical Corporate Summary
Table 116. Tianmen Hengchang Chemical Alirocumab Product Offerings
Table 117. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 118. WeiShi Reagent Corporate Summary
Table 119. WeiShi Reagent Alirocumab Product Offerings
Table 120. WeiShi Reagent Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 121. Wuhan Dingxintong Pharmaceutical Corporate Summary
Table 122. Wuhan Dingxintong Pharmaceutical Alirocumab Product Offerings
Table 123. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 124. Wuhan Fortuna Chemical Corporate Summary
Table 125. Wuhan Fortuna Chemical Alirocumab Product Offerings
Table 126. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 127. Wuhan Sunrise Technology Development Corporate Summary
Table 128. Wuhan Sunrise Technology Development Alirocumab Product Offerings
Table 129. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 130. Wuhan Weisman Bioengineering Corporate Summary
Table 131. Wuhan Weisman Bioengineering Alirocumab Product Offerings
Table 132. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 133. Alirocumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 134. Global Alirocumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 135. Global Alirocumab Production by Region, 2017-2022 (Kg)
Table 136. Global Alirocumab Production by Region, 2023-2028 (Kg)
Table 137. Alirocumab Market Opportunities & Trends in Global Market
Table 138. Alirocumab Market Drivers in Global Market
Table 139. Alirocumab Market Restraints in Global Market
Table 140. Alirocumab Raw Materials
Table 141. Alirocumab Raw Materials Suppliers in Global Market
Table 142. Typical Alirocumab Downstream
Table 143. Alirocumab Downstream Clients in Global Market
Table 144. Alirocumab Distributors and Sales Agents in Global Market
Table 1. Key Players of Alirocumab in Global Market
Table 2. Top Alirocumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Alirocumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Alirocumab Revenue Share by Companies, 2017-2022
Table 5. Global Alirocumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Alirocumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Alirocumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Alirocumab Product Type
Table 9. List of Global Tier 1 Alirocumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alirocumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alirocumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Alirocumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Alirocumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Alirocumab Sales (Kg), 2017-2022
Table 15. By Type - Global Alirocumab Sales (Kg), 2023-2028
Table 16. By Application – Global Alirocumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Alirocumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Alirocumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Alirocumab Sales (Kg), 2017-2022
Table 20. By Application - Global Alirocumab Sales (Kg), 2023-2028
Table 21. By Region – Global Alirocumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Alirocumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Alirocumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Alirocumab Sales (Kg), 2017-2022
Table 25. By Region - Global Alirocumab Sales (Kg), 2023-2028
Table 26. By Country - North America Alirocumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Alirocumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Alirocumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Alirocumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Alirocumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Alirocumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Alirocumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Alirocumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Alirocumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Alirocumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Alirocumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Alirocumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Alirocumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Alirocumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Alirocumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Alirocumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Alirocumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Alirocumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Alirocumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Alirocumab Sales, (Kg), 2023-2028
Table 46. AK Scientific Corporate Summary
Table 47. AK Scientific Alirocumab Product Offerings
Table 48. AK Scientific Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Carbosynth Corporate Summary
Table 50. Carbosynth Alirocumab Product Offerings
Table 51. Carbosynth Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. TargetMol Chemicals Corporate Summary
Table 53. TargetMol Chemicals Alirocumab Product Offerings
Table 54. TargetMol Chemicals Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Beijing Aomi Jiade Pharmaceutical Technology Corporate Summary
Table 56. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offerings
Table 57. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Hefei Hirisun Pharmatech Corporate Summary
Table 59. Hefei Hirisun Pharmatech Alirocumab Product Offerings
Table 60. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Hubei Widely Chemical Technology Corporate Summary
Table 62. Hubei Widely Chemical Technology Alirocumab Product Offerings
Table 63. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Hubei Xingcheng Biotechnology Corporate Summary
Table 65. Hubei Xingcheng Biotechnology Alirocumab Product Offerings
Table 66. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Hubei Zhongshan Medical Technology Corporate Summary
Table 68. Hubei Zhongshan Medical Technology Alirocumab Product Offerings
Table 69. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 71. Jiangxi Ruiweier Biotechnology Alirocumab Product Offerings
Table 72. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Kailide Biomedical Technology Corporate Summary
Table 74. Kailide Biomedical Technology Alirocumab Product Offerings
Table 75. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Nantong Feiyu Biological Technology Corporate Summary
Table 77. Nantong Feiyu Biological Technology Alirocumab Product Offerings
Table 78. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Nantong Hi-Future Biotechnology Corporate Summary
Table 80. Nantong Hi-Future Biotechnology Alirocumab Product Offerings
Table 81. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Shanghai Baishikai Chemical Technology Corporate Summary
Table 83. Shanghai Baishikai Chemical Technology Alirocumab Product Offerings
Table 84. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Shanghai Biochempartner Corporate Summary
Table 86. Shanghai Biochempartner Alirocumab Product Offerings
Table 87. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Shanghai Loulan Biotechnology Corporate Summary
Table 89. Shanghai Loulan Biotechnology Alirocumab Product Offerings
Table 90. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Shanghai Macklin Biochemical Corporate Summary
Table 92. Shanghai Macklin Biochemical Alirocumab Product Offerings
Table 93. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Shanghai Minkai Biotechnology Corporate Summary
Table 95. Shanghai Minkai Biotechnology Alirocumab Product Offerings
Table 96. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 97. Shanghai Ruihui Chemical Technology Corporate Summary
Table 98. Shanghai Ruihui Chemical Technology Alirocumab Product Offerings
Table 99. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 100. Shanghai Saimai Biotechnology Corporate Summary
Table 101. Shanghai Saimai Biotechnology Alirocumab Product Offerings
Table 102. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 103. Shanghai Yifei Biotechnology Corporate Summary
Table 104. Shanghai Yifei Biotechnology Alirocumab Product Offerings
Table 105. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 106. Sichuan Weiqi Biotechnology Corporate Summary
Table 107. Sichuan Weiqi Biotechnology Alirocumab Product Offerings
Table 108. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 109. Taizhou KEDE Chemical Corporate Summary
Table 110. Taizhou KEDE Chemical Alirocumab Product Offerings
Table 111. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 112. Taizhou Kerui Bio-Technology Corporate Summary
Table 113. Taizhou Kerui Bio-Technology Alirocumab Product Offerings
Table 114. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 115. Tianmen Hengchang Chemical Corporate Summary
Table 116. Tianmen Hengchang Chemical Alirocumab Product Offerings
Table 117. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 118. WeiShi Reagent Corporate Summary
Table 119. WeiShi Reagent Alirocumab Product Offerings
Table 120. WeiShi Reagent Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 121. Wuhan Dingxintong Pharmaceutical Corporate Summary
Table 122. Wuhan Dingxintong Pharmaceutical Alirocumab Product Offerings
Table 123. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 124. Wuhan Fortuna Chemical Corporate Summary
Table 125. Wuhan Fortuna Chemical Alirocumab Product Offerings
Table 126. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 127. Wuhan Sunrise Technology Development Corporate Summary
Table 128. Wuhan Sunrise Technology Development Alirocumab Product Offerings
Table 129. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 130. Wuhan Weisman Bioengineering Corporate Summary
Table 131. Wuhan Weisman Bioengineering Alirocumab Product Offerings
Table 132. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 133. Alirocumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 134. Global Alirocumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 135. Global Alirocumab Production by Region, 2017-2022 (Kg)
Table 136. Global Alirocumab Production by Region, 2023-2028 (Kg)
Table 137. Alirocumab Market Opportunities & Trends in Global Market
Table 138. Alirocumab Market Drivers in Global Market
Table 139. Alirocumab Market Restraints in Global Market
Table 140. Alirocumab Raw Materials
Table 141. Alirocumab Raw Materials Suppliers in Global Market
Table 142. Typical Alirocumab Downstream
Table 143. Alirocumab Downstream Clients in Global Market
Table 144. Alirocumab Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Alirocumab Segment by Type
Figure 2. Alirocumab Segment by Application
Figure 3. Global Alirocumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alirocumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alirocumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Alirocumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Alirocumab Revenue in 2021
Figure 9. By Type - Global Alirocumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Alirocumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Alirocumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Alirocumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Alirocumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Alirocumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Alirocumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Alirocumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Alirocumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Alirocumab Sales Market Share, 2017-2028
Figure 19. US Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Alirocumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Alirocumab Sales Market Share, 2017-2028
Figure 24. Germany Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Alirocumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Alirocumab Sales Market Share, 2017-2028
Figure 33. China Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Alirocumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Alirocumab Sales Market Share, 2017-2028
Figure 40. Brazil Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Alirocumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Alirocumab Sales Market Share, 2017-2028
Figure 44. Turkey Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Alirocumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Alirocumab by Region, 2021 VS 2028
Figure 50. Alirocumab Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Alirocumab Segment by Type
Figure 2. Alirocumab Segment by Application
Figure 3. Global Alirocumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alirocumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alirocumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Alirocumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Alirocumab Revenue in 2021
Figure 9. By Type - Global Alirocumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Alirocumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Alirocumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Alirocumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Alirocumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Alirocumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Alirocumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Alirocumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Alirocumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Alirocumab Sales Market Share, 2017-2028
Figure 19. US Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Alirocumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Alirocumab Sales Market Share, 2017-2028
Figure 24. Germany Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Alirocumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Alirocumab Sales Market Share, 2017-2028
Figure 33. China Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Alirocumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Alirocumab Sales Market Share, 2017-2028
Figure 40. Brazil Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Alirocumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Alirocumab Sales Market Share, 2017-2028
Figure 44. Turkey Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Alirocumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Alirocumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Alirocumab by Region, 2021 VS 2028
Figure 50. Alirocumab Industry Value Chain
Figure 51. Marketing Channels
